You are here: Industry Insights > human

News List

Human T-Cell Leukemia Virus (HTLV) Treatments: A Focus on Cepharanthine David Orchard-Webb
August 01, 2024
Human T-cell leukemia virus is a retrovirus that infects T-cells. One promising therapeutic agent is Cepharanthine, a natural alkaloid with antiviral properties.
MIMETAS Contributes With Human Organ-on-Chip Data to IND Application by Argenx Biotech Newswire
July 12, 2024
MIMETAS announced an Investigational New Drug (IND) filing by argenx and was supported by data from MIMETAS.
What are the Human Errors in Pharma Industry and How to Prevent them? Muhammad Asim Niazi
July 13, 2023
Process and manufacturing industries worldwide are prone to human errors, the most common error type faced by these industries.
Human trial data of oral small molecule PD-1/PD-L1 inhibitors were first released PharmaSources/Xiaoyaowan
December 02, 2021
Recently, Incyte of the United States reported the Phase I clinical data of oral small molecule PD-L1 inhibitor INCB086550 in Journal for ImmunoTherapy of Cancer.
The Impact of the Human Genome Project on China Pharmaceutical Industry 20 Years Later Lin Zhang
December 24, 2020
The Human Genome Project (HGP) is the first and greatest endeavor so far to understand ourselves and all other types of life through the vast international collaboration.
Microtech Announces First Human Case of Implantable Microsensor for Heart Failure PRNewswire
December 27, 2024
Microtech announced that it has initiated human clinical trials of their microsensor platform, in a trial to measure atrial pressures important for the treatment of heart failure.
CBC Group R-Bridge Healthcare Fund Announces up to US$50 Million Financing for Human Investments Ltd. to Fund Motiva® Market Expansion PR Newswire
December 12, 2024
R-Bridge Healthcare Fund ("R-Bridge") today announced the closing of a non-dilutive growth financing facility of up to US$50 million for Human Investments Ltd.
Adoption of an Exclusive Human Milk Diet Reduces Malnutrition Rates Among Vulnerable Premature Infants in Sydney Hospital PRNewswire
December 10, 2024
Prolacta Bioscience®, the world's leading hospital provider of 100% human milk-based nutritional products, today announced results of an interim subgroup analysis of a prospective observational study.
MIMETAS and Yamaha Motor Sign Joint Marketing Agreement to Advance Automated Human Disease Model Applications for Drug Development B3C newswire
November 30, 2023
MIMETAS, a leader in human 3D disease modeling, and Yamaha Motor Co., Ltd., a developer of the CELL HANDLER™, announce a strategic joint marketing agreement
SciRhom Files Clinical Trial Application for First-in-Human Trials of Novel Antibody Against Autoimmune Diseases B3C newswire
November 16, 2023
SciRhom GmbH, a pioneering biotech enterprise specialized in developing first-in-class therapeutic antibodies, announced today the achievement of a significant milestone in its development pipeline.